Position in BMY
as of Mar 31, 2026
· filed May 18, 2026
Position Value
$55,368,961
+$2,881,351 QoQ
Shares Held
912,926
-6.2% QoQ
Ownership
0.045%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 92%
None 8%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026JANUS HENDERSON GROUP PLC holds $11,353,030,401 across 14 Drug Manufacturers - General names. BMY ranks #10 (0.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
4,347,394 | $3,998,602,577 | |
| 2 | AZN |
Astrazeneca PLC
|
11,949,424 | $2,356,665,399 | |
| 3 | JNJ |
Johnson & Johnson
|
7,872,478 | $1,924,348,519 | |
| 4 | ABBV |
AbbVie Inc.
|
6,931,036 | $1,507,431,018 | |
| 5 | AMGN |
Amgen Inc
|
1,107,159 | $389,553,892 | |
| 6 | NVS |
Novartis AG
|
2,275,938 | $347,649,529 | |
| 7 | MRK |
Merck & Co., Inc.
|
2,880,199 | $346,459,135 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,972,639 | $274,926,696 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $55,368,961 | 912,926 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $52,487,610 | 973,074 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $43,801,976 | 971,219 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $44,994,759 | 972,019 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $72,126,712 | 1,182,599 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $134,363,539 | 2,375,593 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $183,923,178 | 3,554,758 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $18,567,481 | 447,086 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $24,703,499 | 455,532 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $24,875,292 | 484,804 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $31,204,799 | 537,643 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $191,830,173 | 2,999,690 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $252,911,842 | 3,648,995 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $436,033,043 | 6,060,223 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $526,081,212 | 7,400,214 | Shares | Defined | 2023-01-13 | |
| 2022-06-30 | $520,409,043 | 6,758,559 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $677,293,875 | 9,274,187 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $550,427,670 | 8,828,030 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $526,829,266 | 8,903,655 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $593,677,524 | 8,884,728 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $990,461,784 | 15,689,241 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $1,441,426,777 | 23,237,575 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $1,431,542,038 | 23,744,270 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,245,498,130 | 21,181,941 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,207,975,875 | 21,671,616 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||